Funds holding METAGENOMI THERAPEUTICS INC
ISIN US59102M1045 · United States
- Fund holders
- 14
- Of which ETFs
- 1 13 other funds
- Value held
- ≈ 2.4M $ 2.3M $ · 137.9K €
- Share of capital
- 5.0 % of 37.8M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 741,407 | 882.3K $ | 1.96 % | as of Jun 30, 2026 ↗ | |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 327,100 | 389.2K $ | 0.39 % | 0.87 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 315,460 | 375.4K $ | 0.00 % | 0.84 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 189,092 | 257.2K $ | 0.00 % | 0.50 % | as of May 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 95,479 | 113.6K $ | 0.01 % | 0.25 % | as of Jun 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 62,200 | 74K $ | 0.05 % | 0.16 % | as of Jun 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 47,211 | 64.2K $ | 0.12 % | as of May 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 36,088 | 49.1K $ | 0.10 % | as of May 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 21,951 | 29.9K $ | 0.00 % | 0.06 % | as of May 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 20,833 | 24.8K $ | 0.06 % | as of Jun 30, 2026 ↗ | |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 6,882 | 8.2K $ | 0.00 % | 0.02 % | as of Jun 30, 2026 ↗ |
| Spectrum Fund Meeder Funds | 5,496 | 6.5K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 2,600 | 3.1K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 137.9K € | 0.17 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.39 % | as of Jun 30, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.17 % | as of Dec 31, 2025 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.05 % | as of Jun 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.01 % | as of Jun 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Jun 30, 2026 ↗ |
| Spectrum Fund Meeder Funds | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 13 | 0 | 1,871,799 | +4.5 % |
| 2026Q2 | 13 | -1 | 1,790,960 | -0.5 % |
| 2026Q1 | 14 | +1 | 1,799,156 | +12.9 % |
| 2025Q4 | 13 | -24 | 1,593,415 | -18.2 % |
| 2025Q3 | 37 | -32 | 1,948,224 | -42.3 % |
| 2025Q2 | 69 | +6 | 3,374,512 | +20.7 % |
| 2025Q1 | 63 | +10 | 2,796,752 | +199.0 % |
| 2024Q4 | 53 | +26 | 935,366 | +82.0 % |
| 2024Q3 | 27 | +15 | 513,900 | +17.0 % |
| 2024Q2 | 12 | 439,185 |
Institutional managers
44 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 787,900 | 1.1M $ | as of Mar 31, 2026 |
| Catalio Capital Management, LP | 528,993 | 708.9K $ | as of Mar 31, 2026 |
| Peapod Lane Capital LLC | 516,761 | 682.9K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 496,767 | 665.7K $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 395,800 | 530.4K $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 382,153 | 512.1K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 358,200 | 480.2K $ | as of Mar 31, 2026 |
| PURA VIDA INVESTMENTS, LLC | 264,391 | 354.3K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 230,134 | 308.4K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 202,138 | 270.9K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 170,104 | 227.9K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 151,440 | 202.9K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 120,427 | 161.4K $ | as of Mar 31, 2026 |
| Resolute Advisors LLC | 89,944 | 120.5K $ | as of Mar 31, 2026 |
| Man Group plc | 78,636 | 105.4K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 75,172 | 100.7K $ | as of Mar 31, 2026 |
| RBF Capital, LLC | 64,021 | 85.8K $ | as of Mar 31, 2026 |
| BBR PARTNERS, LLC | 53,403 | 71.6K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 40,582 | 54.4K $ | as of Mar 31, 2026 |
| Fortitude Advisory Group L.L.C. | 37,190 | 49.8K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 27,566 | 36.9K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 27,521 | 36.9K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 16,993 | 22.8K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 16,834 | 22.6K $ | as of Mar 31, 2026 |
| UBS Group AG | 16,098 | 21.6K $ | as of Mar 31, 2026 |
Declared shareholders of METAGENOMI THERAPEUTICS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Thomas Brian C. | 7.30 % | 2,762,142 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding METAGENOMI THERAPEUTICS INC". https://titelia.com/en/stocks/metagenomi-therapeutics-inc-US59102M1045